Talisman selected to participate at the Fast-Track Programme to Barcelona-Catalonia Life Science Hub
Talisman Therapeutics is delighted to be one of 10 biotech and life sciences companies from the UK to have been selected to participate at the Fast-Track Programme to Barcelona-Catalonia Life Science Hub, Catalonia Trade & Investment’s initiative for UK firms looking to expand to Spanish-speaking markets.
Talisman will also attend a market access session in February led by the Department of International Trade from the UK and by Alira Health, an international advisory firm specializing in Spain and Latin America.
“We very much enjoyed the session and look forward to further discussions. We see a lot of potential in working more closely with the science base across Catalonia”, said Mark Treherne, Chairperson of the company.